Compare MRK & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRK | FOXX |
|---|---|---|
| Founded | 2000 | 2017 |
| Country | United States | United States |
| Employees | N/A | 25 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.8B | 17.3M |
| IPO Year | 1995 | N/A |
| Metric | MRK | FOXX |
|---|---|---|
| Price | $148.61 | $2.50 |
| Analyst Decision | Buy | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $125.59 | N/A |
| AVG Volume (30 Days) | ★ 5.5M | 5.3K |
| Earning Date | 04-30-2026 | 05-14-2026 |
| Dividend Yield | ★ 3.06% | N/A |
| EPS Growth | ★ 8.01 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $65,011,000,000.00 | N/A |
| Revenue This Year | $3.61 | N/A |
| Revenue Next Year | $5.41 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $78.03 | $1.71 |
| 52 Week High | $157.00 | $7.90 |
| Indicator | MRK | FOXX |
|---|---|---|
| Relative Strength Index (RSI) | 56.54 | 46.10 |
| Support Level | $145.75 | $2.29 |
| Resistance Level | $152.80 | $4.84 |
| Average True Range (ATR) | 3.14 | 0.21 |
| MACD | -0.44 | -0.00 |
| Stochastic Oscillator | 56.04 | 51.11 |
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.